Roivant Sciences Ltd. reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported revenue was USD 37.1 million compared to USD 12.53 million a year ago. Net loss was USD 304.33 million compared to USD 291.59 million a year ago. Basic loss per share from continuing operations was USD 0.4 compared to USD 0.42 a year ago.
For the six months, revenue was USD 58.73 million compared to USD 16.85 million a year ago. Net loss was USD 596.14 million compared to USD 623.4 million a year ago. Basic loss per share from continuing operations was USD 0.78 compared to USD 0.89 a year ago.